1.Fry AM, et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002. Journal of the American Medical Association 2005; 294: 2712–2719.
2.Poehling KA, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics 2004; 114: 755–761.
3.De Wals P, et al. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatric Infectious Disease Journal 2008; 27: 963–968.
4.Grijalva CG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369: 1179–1186.
5.Zhou F, et al. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Archives of Pediatrics & Adolescent Medicine 2007; 161: 1162–1168.
6.Thomsen RW, et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. Journal of Internal Medicine 2006; 259: 410–417.
7.Baine WB, Yu W, Summe JP. Epidemiologic trends in the hospitalization of elderly Medicare patients for pneumonia, 1991–1998. American Journal of Public Health 2001; 91: 1121–1123.
8.Ellis SE, et al. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. Journal of the American Geriatrics Society 2003; 51: 761–767.
9.Kornum JB, et al. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008; 31: 1541–1545.
10.Nichol KL, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. New England Journal of Medicine 2007; 357: 1373–1381.
11.Nordin J, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases 2001; 184: 665–670.
12.Jackson LA, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. International Journal of Epidemiology 2006; 35: 337–344.
13.Thomsen RW, et al. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Archives of Internal Medicine 2008; 168: 2081–2087.
14.Schlienger RG, et al. Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy 2007; 27: 325–332.
15.Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Annals of Internal Medicine 2008; 149: 391–398.
16.Hennessy S, et al. Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. Journal of Clinical Epidemiology 2007; 60: 911–918.
17.Jackson ML, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008; 372: 398–405.
18.Jackson LA, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. New England Journal of Medicine 2003; 348: 1747–1755.
19.Nelson JC, et al. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008; 26: 4947–4954.
20.Breiman L, et al. Classification and Regression Trees. Boca Raton, FL: Chapman & Hall/CRC, 1984.
21.R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2008 (www.R-project.org).
22.Guevara RE, et al. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. American Journal of Epidemiology 1999; 149: 282–289.
23.Marrie TJ, Durant H, Sealy E. Pneumonia – the quality of medical records data. Medical Care 1987; 25: 20–24.
24.Aronsky D, et al. Accuracy of administrative data for identifying patients with pneumonia. American Journal of Medical Quality 2005; 20: 319–328.
25.van de Garde EM, et al. International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. Journal of Clinical Epidemiology 2007; 60: 834–838.
26.Whittle J, et al. Community-acquired pneumonia: can it be defined with claims data? American Journal of Medical Quality 1997; 12: 187–193.
27.Skull SA, et al. ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged ⩾65 years. Epidemiology and Infection 2008; 136: 232–240.